Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Accendra Health, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
ACH
New York
3841
www.accendrahealth.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Accendra Health, Inc.
Accendra Health Receives Delisting Notice From the New York Stock Exchange
- Nov 17th, 2026 4:30 pm
BLUE SHIELD OF CALIFORNIA EXPANDS COLLABORATION WITH ACCENDRA HEALTH TO IMPROVE ACCESS TO HOME-BASED CARE
- Nov 16th, 2026 2:05 pm
NYSE to Commence Delisting Proceedings Against Accendra Health, Inc. (ACH)
- Nov 16th, 2026 2:00 pm
Accendra (ACH) Q3 2026 Earnings Call Transcript
- Nov 6th, 2026 10:18 am
Accendra Health Inc (ACH) (Q3 2026) Earnings Call Highlights: Revenue Slips 1% as Guidance Cut ...
- Nov 6th, 2026 2:18 am
Accendra Health Reports Third Quarter 2026 Financial Results
- Nov 5th, 2026 2:01 pm
Orosur Mining shares dip despite fresh gold drilling results in Colombia
- Nov 4th, 2026 4:00 am
Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029
- Nov 2nd, 2026 4:45 am
Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard
- Oct 30th, 2026 2:45 pm
Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call
- Oct 22nd, 2026 2:05 pm
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
- Oct 9th, 2026 2:05 pm
New Strong Sell Stocks for October 9th
- Oct 9th, 2026 3:12 am
New Strong Sell Stocks for October 6th
- Oct 6th, 2026 12:40 am
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
- Sep 17th, 2026 4:30 am
Accendra Health drops equity issuance plan as CEO succession process advances
- Aug 17th, 2026 6:29 am
Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
- Aug 17th, 2026 4:30 am
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
- Aug 10th, 2026 4:50 am
Accendra Health Reports Second Quarter 2026 Financial Results
- Aug 10th, 2026 4:45 am
Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
- Aug 10th, 2026 4:30 am
Scroll